Skip to content
2000
image of An Overview of the Association of the Urinary Tract Microbiome with Various Diseases and Implications for Therapeutics

Abstract

The urinary tract (UT) was once considered sterile, but now it is known to host a diverse community of microorganisms, known as the urinary microbiome. The collective microbiota is made up of bacteria, fungi, and viruses, necessary for maintaining UT health. This review aims to synthesize current knowledge on the urinary microbiome and clarify its emerging role as a key modulator in both health and a wide spectrum of UT disorders. Dysbiosis within this microbial community has been linked to conditions such as urinary tract infections (UTIs), interstitial cystitis/bladder pain syndrome (IC/BPS), urinary incontinence, urolithiasis, benign prostatic hyperplasia (BPH), and even urinary tract malignancies. Advances in methodologies, such as expanded quantitative urine culture and metagenomics, have provided valuable insights into microbial variability influenced by factors like age, sex, and disease conditions. Additionally, this review explores the therapeutic potential of probiotics and bacteriophages, as well as the association of urinary microbiota with autoimmune and inflammatory conditions. Special emphasis is placed on translational relevance, including emerging microbiome-targeted therapies and personalized interventions for UTIs. Ethical considerations allied with UT microbiome research, such as data privacy, informed consent, and equitable access to emerging therapies, are also discussed. Despite substantial progress, challenges such as methodological heterogeneity, a lack of longitudinal data, and unresolved causal relationships persist. The study concludes by identifying key knowledge gaps and proposing future directions for multidisciplinary research to advance therapeutic innovation in urological health.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/mrmc/10.2174/0113895575398906250825113635
2025-09-10
2025-09-21

  • From This Site

    /content/journals/mrmc/10.2174/0113895575398906250825113635
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Tang J. Microbiome in the urinary system - A review. AIMS Microbiol. 2017 3 2 143 154 10.3934/microbiol.2017.2.143 31294154
    [Google Scholar]
  2. Hazen J.E. The enemy within: An investigation of the intracellular bacteria in urinary tract infections. Doctor of Philosophy. Washington University in St Louis 2022
    [Google Scholar]
  3. Pratt C. Modified reporting of positive urine cultures to reduce treatment of catheter-associated asymptomatic bacteriuria (CAASB) among inpatients: A randomized controlled trial. Master's Thesis, Memorial University of Newfoundland 2021
    [Google Scholar]
  4. Colella M. Topi S. Palmirotta R. D’Agostino D. Charitos I.A. Lovero R. Santacroce L. An overview of the microbiota of the human urinary tract in health and disease: Current issues and perspectives. Life 2023 13 7 1486 10.3390/life13071486 37511861
    [Google Scholar]
  5. Sirisinha S. The potential impact of gut on your health: Current status and future challenges. Asian Pac. J. Allergy Immunol. 2016 34 4 249 264 10.12932/AP0803 28042926
    [Google Scholar]
  6. Jones J. Murphy C.P. Sleator R.D. Culligan E.P. The urobiome, urinary tract infections, and the need for alternative therapeutics. Microb Pathog. 2021 161 Part B 105295 10.1016/j.micpath.2021.105295
    [Google Scholar]
  7. Duerkop B.A. Vaishnava S. Hooper L.V. Immune responses to the microbiota at the intestinal mucosal surface. Immunity 2009 31 3 368 376 10.1016/j.immuni.2009.08.009 19766080
    [Google Scholar]
  8. Jones-Freeman B. Chonwerawong M. Marcelino V.R. Deshpande A.V. Forster S.C. Starkey M.R. The microbiome and host mucosal interactions in urinary tract diseases. Mucosal Immunol. 2021 14 4 779 792 10.1038/s41385‑020‑00372‑5 33542492
    [Google Scholar]
  9. Rowan-Nash A.D. Korry B.J. Mylonakis E. Belenky P. Cross-domain and viral interactions in the microbiome. Microbiol. Mol. Biol. Rev. 2019 83 10.1128/MMBR.00044‑18
    [Google Scholar]
  10. Neugent M.L. Kumar A. Hulyalkar N.V. Lutz K.C. Nguyen V.H. Fuentes J.L. Zhang C. Nguyen A. Sharon B.M. Kuprasertkul A. Arute A.P. Ebrahimzadeh T. Natesan N. Xing C. Shulaev V. Li Q. Zimmern P.E. Palmer K.L. De Nisco N.J. Recurrent urinary tract infection and estrogen shape the taxonomic ecology and function of the postmenopausal urogenital microbiome. Cell Rep. Med. 2022 3 10 100753 10.1016/j.xcrm.2022.100753 36182683
    [Google Scholar]
  11. Kim J.M. Park Y.J. Lactobacillus and urine microbiome in association with urinary tract infections and bacterial vaginosis. Urogenit. Tract. Infect. 2018 13 1 7 13 10.14777/uti.2018.13.1.7
    [Google Scholar]
  12. Javan Balegh Marand A. Van Koeveringe G.A. Janssen D. Vahed N. Vögeli T-A. Heesakkers J. Hajebrahimi S. Rahnama’i M.S. Urinary microbiome and its correlation with disorders of the genitourinary system. Urol. J. 2021 18 3 259 270 10.22037/uj.v16i7.5976 33550579
    [Google Scholar]
  13. Suarez Arbelaez M.C. Monshine J. Porto J.G. Shah K. Singh P.K. Roy S. Amin K. Marcovich R. Herrmann T.R.W. Shah H.N. The emerging role of the urinary microbiome in benign noninfectious urological conditions: An up-to-date systematic review. World J. Urol. 2023 41 11 2933 2948 10.1007/s00345‑023‑04588‑5 37737900
    [Google Scholar]
  14. Yuan F. Huang Z. Yang T. Wang G. Li P. Yang B. Li J. Pathogenesis of Proteus mirabilis in catheter-associated urinary tract infections. Urol. Int. 2021 105 5-6 354 361 10.1159/000514097 33691318
    [Google Scholar]
  15. Pulipati S. Babu P.S. Narasu M.L. Anusha N. An overview on urinary tract infections and effective natural remedies. Faslnamah-i Giyahan-i Daruyi 2017 5 50 56
    [Google Scholar]
  16. Sobel J.D. Vazquez J.A. Fungal infections of the urinary tract. World J. Urol. 1999 17 6 410 414 10.1007/s003450050167 10654372
    [Google Scholar]
  17. Paduch D.A. Viral lower urinary tract infections. Curr. Urol. Rep. 2007 8 4 324 335 10.1007/s11934‑007‑0080‑y 18519018
    [Google Scholar]
  18. Price T.K. Wolff B. Halverson T. Limeira R. Brubaker L. Dong Q. Mueller E.R. Wolfe A.J. Temporal dynamics of the adult female lower urinary tract microbiota. MBio 2020 11 2 10.1128/mbio.00475‑20
    [Google Scholar]
  19. Meštrović T. Matijašić M. Perić M. Čipčić Paljetak H. Barešić A. Verbanac D. The role of gut, vaginal, and urinary microbiome in urinary tract infections: From bench to bedside. Diagnostics 2020 11 1 7 10.3390/diagnostics11010007 33375202
    [Google Scholar]
  20. Hickling D.R. Sun T.T. Wu X.R. Anatomy and physiology of the urinary tract: relation to host defense and microbial infection. Microbiol. Spectr. 2015 3 4 3.4.21 10.1128/microbiolspec.UTI‑0016‑2012 26350322
    [Google Scholar]
  21. Workowski K.A. Bachmann L.H. Chan P.A. Johnston C.M. Muzny C.A. Park I. Reno H. Zenilman J.M. Bolan G.A. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm. Rep. 2021 70 4 1 187 10.15585/mmwr.rr7004a1 34292926
    [Google Scholar]
  22. Ambrogi M. Neuroendocrine Cells and Serotonin Mediated a Urethral Defense Against UTIs. Doctor of Philosophy. The University of Wisconsin - Madison 2024
    [Google Scholar]
  23. Storme O. Tirán Saucedo J. Garcia-Mora A. Dehesa-Dávila M. Naber K.G. Risk factors and predisposing conditions for urinary tract infection. Ther. Adv. Urol. 2019 11 1756287218814382 10.1177/1756287218814382 31105772
    [Google Scholar]
  24. Zeng G. Zhu W. Lam W. Bayramgil A. Treatment of urinary tract infections in the old and fragile. World J. Urol. 2020 38 11 2709 2720 10.1007/s00345‑020‑03159‑2 32221713
    [Google Scholar]
  25. Ragnarsdóttir B. Lutay N. Grönberg-Hernandez J. Köves B. Svanborg C. Genetics of innate immunity and UTI susceptibility. Nat. Rev. Urol. 2011 8 8 449 468 10.1038/nrurol.2011.100 21750501
    [Google Scholar]
  26. Kawalec A. Zwolińska D. Emerging role of microbiome in the prevention of urinary tract infections in children. Int. J. Mol. Sci. 2022 23 2 870 10.3390/ijms23020870 35055056
    [Google Scholar]
  27. Whiteside S.A. Razvi H. Dave S. Reid G. Burton J.P. The microbiome of the urinary tract - A role beyond infection. Nat. Rev. Urol. 2015 12 2 81 90 10.1038/nrurol.2014.361 25600098
    [Google Scholar]
  28. Neugent M.L. Hulyalkar N.V. Nguyen V.H. Zimmern P.E. De Nisco N.J. Advances in understanding the human urinary microbiome and its potential role in urinary tract infection. MBio 2020 11 2 10 1128 10.1128/mbio.00218‑20
    [Google Scholar]
  29. La Scola C. Guiducci C. Montini G. Urinary tract infections: An overview of urine collection, imaging, and prevention. Pediatric Urology. Lima M. Manzoni G. Milano Springer 2014 341 351 10.1007/978‑88‑470‑5693‑0_28
    [Google Scholar]
  30. Ghaffary C. Yohannes A. Villanueva C. Leslie S.W. A practical approach to difficult urinary catheterizations. Curr. Urol. Rep. 2013 14 6 565 579 10.1007/s11934‑013‑0364‑3 23959835
    [Google Scholar]
  31. Gasiorek M. Hsieh M.H. Forster C.S. Utility of DNA next-generation sequencing and expanded quantitative urine culture in diagnosis and management of chronic or persistent lower urinary tract symptoms. J. Clin. Microbiol. 2019 58 1 10 1128 10.1128/JCM.00204‑19
    [Google Scholar]
  32. Fritzenwanker M. Imirzalioglu C. Chakraborty T. Wagenlehner F.M. Modern diagnostic methods for urinary tract infections. Expert Rev. Anti Infect. Ther. 2016 14 11 1047 1063 10.1080/14787210.2016.1236685 27624932
    [Google Scholar]
  33. Xu R. Deebel N. Casals R. Dutta R. Mirzazadeh M. A new gold rush: a review of current and developing diagnostic tools for urinary tract infections. Diagnostics 2021 11 3 479 10.3390/diagnostics11030479 33803202
    [Google Scholar]
  34. Hilt E.E. McKinley K. Pearce M.M. Rosenfeld A.B. Zilliox M.J. Mueller E.R. Brubaker L. Gai X. Wolfe A.J. Schreckenberger P.C. Urine is not sterile: Use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J. Clin. Microbiol. 2014 52 3 871 876 10.1128/JCM.02876‑13 24371246
    [Google Scholar]
  35. Deen N.S. Ahmed A. Tasnim N.T. Khan N. Clinical relevance of expanded quantitative urine culture in health and disease. Front. Cell. Infect. Microbiol. 2023 13 1210161 10.3389/fcimb.2023.1210161 37593764
    [Google Scholar]
  36. Price T.K. Dune T. Hilt E.E. Thomas-White K.J. Kliethermes S. Brincat C. Brubaker L. Wolfe A.J. Mueller E.R. Schreckenberger P.C. The clinical urine culture: Enhanced techniques improve detection of clinically relevant microorganisms. J. Clin. Microbiol. 2016 54 5 1216 1222 10.1128/JCM.00044‑16 26962083
    [Google Scholar]
  37. Kali A. Joseph N.M. Pravin Charles M.V. Performance of chromogenic media for Candida in rapid presumptive identification of Candida species from clinical materials. Pharmacognosy Res. 2015 7 Suppl. 1 S69 S73 10.4103/0974‑8490.150528 26109791
    [Google Scholar]
  38. Brubaker L. Chai T.C. Horsley H. Khasriya R. Moreland R.B. Wolfe A.J. Tarnished gold—the “standard” urine culture: reassessing the characteristics of a criterion standard for detecting urinary microbes. Front. Urol. 2023 3 1206046 10.3389/fruro.2023.1206046
    [Google Scholar]
  39. Ksiezarek M.D. Comprehensive urogenital microbiome profiling: Towards better understanding of female urinary tract in health and disease. Portugal Universidade do Porto 2022
    [Google Scholar]
  40. Mejuto P. Luengo M. Díaz-Gigante J. Automated flow cytometry: An alternative to urine culture in a routine clinical microbiology laboratory? Int. J. Microbiol. 2017 2017 1 1 8 10.1155/2017/8532736 29090008
    [Google Scholar]
  41. Oros D. Ceprnja M. Zucko J. Cindric M. Hozic A. Skrlin J. Barisic K. Melvan E. Uroic K. Kos B. Starcevic A. Identification of pathogens from native urine samples by MALDI-TOF/TOF tandem mass spectrometry. Clin. Proteomics 2020 17 1 25 10.1186/s12014‑020‑09289‑4 32581661
    [Google Scholar]
  42. Batur T. Diagnostic performance evaluation of complete urinalysis in the diagnosis of urinary tract infection: Complete urinalysis in the diagnosis of urinary tract infection. Chronicles Precision Medical Researchers 2022 3 2 52 56
    [Google Scholar]
  43. Chai T.C. Wolfe A.J. Brubaker L. The urinary microbiome. Infect. Dis. Clin. North Am. 2024 38 2 241 253 10.1016/j.idc.2024.03.003 38729665
    [Google Scholar]
  44. Cheung F. Loeb C.A. Croglio M.P. Waltzer W.C. Weissbart S.J. Bacteria on urine microscopy is not associated with systemic infection in patients with obstructing urolithiasis. J. Endourol. 2017 31 9 942 945 10.1089/end.2017.0157 28558478
    [Google Scholar]
  45. Regueira-Iglesias A. Balsa-Castro C. Blanco-Pintos T. Tomás I. Critical review of 16S rRNA gene sequencing workflow in microbiome studies: From primer selection to advanced data analysis. Mol. Oral Microbiol. 2023 38 5 347 399 10.1111/omi.12434 37804481
    [Google Scholar]
  46. Barraud O. Ravry C. François B. Daix T. Ploy M.C. Vignon P. Shotgun metagenomics for microbiome and resistome detection in septic patients with urinary tract infection. Int. J. Antimicrob. Agents 2019 54 6 803 808 10.1016/j.ijantimicag.2019.09.009 31536754
    [Google Scholar]
  47. Liao Y. Emerging tools for uncovering genetic and transcriptomic heterogeneities in bacteria. Biophys. Rev. 2024 16 1 109 124 10.1007/s12551‑023‑01178‑y 38495445
    [Google Scholar]
  48. Abdi G. Tarighat M.A. Jain M. Tendulkar R. Tendulkar M. Barwant M. Revolutionizing Genomics: Exploring the Potential of Next-Generation Sequencing. Advances in Bioinformatics. Singh V. Kumar A. Springer 2024 1 33 10.1007/978‑981‑99‑8401‑5_1
    [Google Scholar]
  49. Moustafa A. Li W. Singh H. Moncera K.J. Torralba M.G. Yu Y. Manuel O. Biggs W. Venter J.C. Nelson K.E. Pieper R. Telenti A. Microbial metagenome of urinary tract infection. Sci. Rep. 2018 8 1 4333 10.1038/s41598‑018‑22660‑8 29531289
    [Google Scholar]
  50. Halwachs B. Madhusudhan N. Krause R. Nilsson R.H. Moissl-Eichinger C. Högenauer C. Thallinger G.G. Gorkiewicz G. Critical issues in mycobiota analysis. Front. Microbiol. 2017 8 180 10.3389/fmicb.2017.00180 28261162
    [Google Scholar]
  51. Bellemain E. Carlsen T. Brochmann C. Coissac E. Taberlet P. Kauserud H. ITS as an environmental DNA barcode for fungi: An in silico approach reveals potential PCR biases. BMC Microbiol. 2010 10 1 189 10.1186/1471‑2180‑10‑189 20618939
    [Google Scholar]
  52. Zhao Y. Zhang W. Zhang X. Application of metagenomic next-generation sequencing in the diagnosis of infectious diseases. Front. Cell. Infect. Microbiol. 2024 14 1458316 10.3389/fcimb.2024.1458316 39619659
    [Google Scholar]
  53. Dasgupta N. Srivastava A. Rao A. Murugkar V. Shroff R. Das G. Microbiome Diagnostics and Interventions in Health and Disease. Microbiome in Human Health. and Disease. Bramhachari P.V. Singapore Springer 2021 157 215 10.1007/978‑981‑16‑3156‑6_10
    [Google Scholar]
  54. Santiago-Rodriguez T.M. Ly M. Bonilla N. Pride D.T. The human urine virome in association with urinary tract infections. Front. Microbiol. 2015 6 14 10.3389/fmicb.2015.00014 25667584
    [Google Scholar]
  55. Guliciuc M. Porav-Hodade D. Mihailov R. Rebegea L.F. Voidazan S.T. Ghirca V.M. Maier A.C. Marinescu M. Firescu D. Exploring the dynamic role of bacterial etiology in complicated urinary tract infections. Medicina 2023 59 9 1686 10.3390/medicina59091686 37763805
    [Google Scholar]
  56. Kelly M.S. Dahl E.M. Jeries L.M. Sysoeva T.A. Karstens L. Characterization of pediatric urinary microbiome at species-level resolution indicates variation due to sex, age, and urologic history. J. Pediatr. Urol. 2024 20 5 884 893 10.1016/j.jpurol.2024.05.016 38862292
    [Google Scholar]
  57. Forster S. C.; Liu, H.; Kurs-Lasky, M.; Ullmer, W.; Krumbeck, J.A.; Shaikh, N. Uromycobiome in infants and toddlers with and without urinary tract infections. Pediatr. Nephrol. 2023 38 7 2117 2123 10.1007/s00467‑022‑05844‑3 36547733
    [Google Scholar]
  58. Wehedy E. Murugesan S. George C.R. Shatat I.F. Al Khodor S. Characterization of the urinary metagenome and virome in healthy children. Biomedicines 2022 10 10 2412 10.3390/biomedicines10102412 36289674
    [Google Scholar]
  59. Mueller E.R. Wolfe A.J. Brubaker L. Female urinary microbiota. Curr. Opin. Urol. 2017 27 3 282 286 10.1097/MOU.0000000000000396 28234750
    [Google Scholar]
  60. Anglim B. Phillips C. Shynlova O. Alarab M. The effect of local estrogen therapy on the urinary microbiome composition of postmenopausal women with and without recurrent urinary tract infections. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2022 33 8 2107 2117 10.1007/s00192‑021‑04832‑9 34003309
    [Google Scholar]
  61. Thomas-White K. Taege S. Limeira R. Brincat C. Joyce C. Hilt E.E. Mac-Daniel L. Radek K.A. Brubaker L. Mueller E.R. Vaginal estrogen therapy is associated with increased Lactobacillus in the urine of postmenopausal women with overactive bladder symptoms. Am. J. Obstet. Gynecol. 2020 223 5 727.e1 727.e11 10.1016/j.ajog.2020.08.006
    [Google Scholar]
  62. Pohl H.G. Groah S.L. Pérez-Losada M. Ljungberg I. Sprague B.M. Chandal N. Caldovic L. Hsieh M. The urine microbiome of healthy men and women differs by urine collection method. Int. Neurourol. J. 2020 24 1 41 51 10.5213/inj.1938244.122 32252185
    [Google Scholar]
  63. El-Alawi S.H. Using culture independent approaches to gain insights into human urinary tract microbiome in healthy male and female individuals. Master of Science. The American University in Cairo AUC 2021
    [Google Scholar]
  64. Fouts D.E. Pieper R. Szpakowski S. Pohl H. Knoblach S. Suh M.J. Huang S.T. Ljungberg I. Sprague B.M. Lucas S.K. Torralba M. Nelson K.E. Groah S.L. Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J. Transl. Med. 2012 10 1 174 10.1186/1479‑5876‑10‑174 22929533
    [Google Scholar]
  65. Singer M. Bacterial interactions in the female genital tract: A triangle affair between pathogens, microbiota, and host. Doctor of Philosophy. Vrije Universiteit Amsterdam 2019
    [Google Scholar]
  66. Tesei D. Jewczynko A. Lynch A. Urbaniak C. Understanding the complexities and changes of the astronaut microbiome for successful long-duration space missions. Life 2022 12 4 495 10.3390/life12040495 35454986
    [Google Scholar]
  67. Brady S.S. Bavendam T.G. Bradway C.K. Conroy B. Dowling-Castronovo A. Epperson C.N. Hijaz A.K. Hsi R.S. Huss K. Kim M. Lazar J. Lee R.K. Liu C.K. Loizou C.N. Miran S. Mody L. Norton J.M. Reynolds W.S. Sutcliffe S. Zhang N. Hokanson J.A. Noncancerous genitourinary conditions as a public health priority: Conceptualizing the hidden burden. Urology 2022 166 39 49 10.1016/j.urology.2021.08.040 34536410
    [Google Scholar]
  68. Krishnaswamy P.H. Basu M. Urinary tract infection in gynaecology and obstetrics. Obstetrics, Gynaecol. Reprod. Med. 2020 30 9 276 282 10.1016/j.ogrm.2020.06.002
    [Google Scholar]
  69. Roth R.S. Liden M. Huttner A. The urobiome in men and women: A clinical review. Clin. Microbiol. Infect. 2023 29 10 1242 1248 10.1016/j.cmi.2022.08.010 36028087
    [Google Scholar]
  70. Pederzoli F. Ferrarese R. Amato V. Locatelli I. Alchera E. Lucianò R. Nebuloni M. Briganti A. Gallina A. Colombo R. Necchi A. Clementi M. Montorsi F. Mancini N. Salonia A. Alfano M. Sex-specific alterations in the urinary and tissue microbiome in therapy-naïve urothelial bladder cancer patients. Eur. Urol. Oncol. 2020 3 6 784 788 10.1016/j.euo.2020.04.002 32345542
    [Google Scholar]
  71. Perez-Carrasco V. Soriano-Lerma A. Soriano M. Gutiérrez-Fernández J. Garcia-Salcedo J.A. Urinary microbiome: Yin and yang of the urinary tract. Front. Cell. Infect. Microbiol. 2021 11 617002 10.3389/fcimb.2021.617002 34084752
    [Google Scholar]
  72. Patangia D.V. Anthony Ryan C. Dempsey E. Paul Ross R. Stanton C. Impact of antibiotics on the human microbiome and consequences for host health. MicrobiologyOpen 2022 11 1 e1260 10.1002/mbo3.1260 35212478
    [Google Scholar]
  73. Josephs-Spaulding J. Krogh T.J. Rettig H.C. Lyng M. Chkonia M. Waschina S. Graspeuntner S. Rupp J. Møller-Jensen J. Kaleta C. Recurrent urinary tract infections: Unraveling the complicated environment of uncomplicated rUTIs. Front. Cell. Infect. Microbiol. 2021 11 562525 10.3389/fcimb.2021.562525 34368008
    [Google Scholar]
  74. Lacerda Mariano L. Ingersoll M.A. The immune response to infection in the bladder. Nat. Rev. Urol. 2020 17 8 439 458 10.1038/s41585‑020‑0350‑8 32661333
    [Google Scholar]
  75. Sorić Hosman I. Cvitković Roić A. Lamot L. A systematic review of the (Un) known host immune response biomarkers for predicting recurrence of urinary tract infection. Front. Med. 2022 9 931717 10.3389/fmed.2022.931717 35860746
    [Google Scholar]
  76. Liu F. Du J. Zhai Q. Hu J. Miller A.W. Ren T. Feng Y. Jiang P. Hu L. Sheng J. Gu C. Yan R. Lv L. Wolfe A.J. Feng N. The bladder microbiome, metabolome, cytokines, and phenotypes in patients with systemic lupus erythematosus. Microbiol. Spectr. 2022 10 5 e00212 e00222 10.1128/spectrum.00212‑22 35913213
    [Google Scholar]
  77. Murray B.O. Flores C. Williams C. Flusberg D.A. Marr E.E. Kwiatkowska K.M. Charest J.L. Isenberg B.C. Rohn J.L. Recurrent urinary tract infection: A mystery in search of better model systems. Front. Cell. Infect. Microbiol. 2021 11 691210 10.3389/fcimb.2021.691210 34123879
    [Google Scholar]
  78. Hiergeist A. Gessner A. Clinical implications of the microbiome in urinary tract diseases. Curr. Opin. Urol. 2017 27 2 93 98 10.1097/MOU.0000000000000367 27898455
    [Google Scholar]
  79. Aragón I.M. Herrera-Imbroda B. Queipo-Ortuño M.I. Castillo E. Del Moral J.S.G. Gómez-Millán J. Yucel G. Lara M.F. The urinary tract microbiome in health and disease. Eur. Urol. Focus 2018 4 1 128 138 10.1016/j.euf.2016.11.001 28753805
    [Google Scholar]
  80. Brauer-Nikonow A. Zimmermann M. How the gut microbiota helps keep us vitaminized. Cell Host Microbe 2022 30 8 1063 1066 10.1016/j.chom.2022.07.010 35952641
    [Google Scholar]
  81. Salazar A.M. Neugent M.L. De Nisco N.J. Mysorekar I.U. Gut-bladder axis enters the stage: Implication for recurrent urinary tract infections. Cell Host Microbe 2022 30 8 1066 1069 10.1016/j.chom.2022.07.008 35952642
    [Google Scholar]
  82. Lee K.W. Song H.Y. Kim Y.H. The microbiome in urological diseases. Investig. Clin. Urol. 2020 61 4 338 348 10.4111/icu.2020.61.4.338 32665990
    [Google Scholar]
  83. Tan C.W. Chlebicki M.P. Urinary tract infections in adults. Singapore Med. J. 2016 57 9 485 490 10.11622/smedj.2016153 27662890
    [Google Scholar]
  84. Mao B.H. Chang Y.F. Scaria J. Chang C.C. Chou L.W. Tien N. Wu J.J. Tseng C.C. Wang M.C. Chang C.C. Hsu Y.M. Teng C.H. Identification of Escherichia coli genes associated with urinary tract infections. J. Clin. Microbiol. 2012 50 2 449 456 10.1128/JCM.00640‑11 22075599
    [Google Scholar]
  85. Yoo J.J. Song J.S. Kim W.B. Yun J. Shin H.B. Jang M.A. Ryu C.B. Kim S.S. Chung J.C. Kuk J.C. Shin E.J. Song H.Y. Yu B.C. Lee E.S. Ryu S. Kim J.H. Jung S.S. Kim Y.H. Gardnerella vaginalis in recurrent urinary tract infection is associated with dysbiosis of the bladder microbiome. J. Clin. Med. 2022 11 9 2295 10.3390/jcm11092295 35566419
    [Google Scholar]
  86. Choi H.W. Lee K.W. Kim Y.H. Microbiome in urological diseases: Axis crosstalk and bladder disorders. Investig. Clin. Urol. 2023 64 2 126 139 10.4111/icu.20220357 36882171
    [Google Scholar]
  87. Guay D.R.P. Contemporary management of uncomplicated urinary tract infections. Drugs 2008 68 9 1169 1205 10.2165/00003495‑200868090‑00002 18547131
    [Google Scholar]
  88. Rowe T.A. Juthani-Mehta M. Urinary tract infection in older adults. Aging Health 2013 9 5 519 528 10.2217/ahe.13.38 24391677
    [Google Scholar]
  89. Gilbert N.M. O’Brien V.P. Lewis A.L. Transient microbiota exposures activate dormant Escherichia coli infection in the bladder and drive severe outcomes of recurrent disease. PLoS Pathog. 2017 13 3 e1006238 10.1371/journal.ppat.1006238 28358889
    [Google Scholar]
  90. O’Brien V.P. Lewis A.L. Gilbert N.M. Bladder exposure to gardnerella activates host pathways necessary for Escherichia coli recurrent UTI. Front. Cell. Infect. Microbiol. 2021 11 788229 10.3389/fcimb.2021.788229 34938672
    [Google Scholar]
  91. Krcmery S. Dubrava M. Krcmery V. Fungal urinary tract infections in patients at risk. Int. J. Antimicrob. Agents 1999 11 3-4 289 291 10.1016/S0924‑8579(99)00032‑1 10394985
    [Google Scholar]
  92. Poloni J.A.T. Rotta L.N. Urine sediment findings and the immune response to pathologies in fungal urinary tract infections caused by Candida spp. J. Fungi (Basel) 2020 6 4 245 10.3390/jof6040245 33114117
    [Google Scholar]
  93. Sathiananthamoorthy S. Characterisation of the urinary microbial community and its association with lower urinary tract symptoms. Doctor of Philosophy. University College London 2018
    [Google Scholar]
  94. Worby C.J. Schreiber H.L. Straub T.J. van Dijk L.R. Bronson R.A. Olson B. Pinkner J.S. Obernuefemann C.L. Muñoz V.L. Paharik A.E. Gut-bladder axis syndrome associated with recurrent UTIs in humans. medRxiv 2021 10.1101/2021.11.15.21266268
    [Google Scholar]
  95. Roth S. “Interstitial cystitis” or “bladder pain syndrome”? Aktuelle Urol. 2008 39 3 163 164 18574911
    [Google Scholar]
  96. Abernethy M.G. Rosenfeld A. White J.R. Mueller M.G. Lewicky-Gaupp C. Kenton K. Urinary microbiome and cytokine levels in women with interstitial cystitis. Obstet. Gynecol. 2017 129 3 500 506 10.1097/AOG.0000000000001892 28178051
    [Google Scholar]
  97. Siddiqui H. Lagesen K. Nederbragt A.J. Jeansson S.L. Jakobsen K.S. Alterations of microbiota in urine from women with interstitial cystitis. BMC Microbiol. 2012 12 1 205 10.1186/1471‑2180‑12‑205 22974186
    [Google Scholar]
  98. Abernethy M.G. Tsuei A. The bladder microbiome and interstitial cystitis: is there a connection? Curr. Opin. Obstet. Gynecol. 2021 33 6 469 473 10.1097/GCO.0000000000000747 34475365
    [Google Scholar]
  99. Xu H. Tamrat N.E. Gao J. Xu J. Zhou Y. Zhang S. Chen Z. Shao Y. Ding L. Shen B. Wei Z. Combined signature of the urinary microbiome and metabolome in patients with interstitial cystitis. Front. Cell. Infect. Microbiol. 2021 11 711746 10.3389/fcimb.2021.711746 34527602
    [Google Scholar]
  100. Nickel J. Stephens-Shields A. Landis J. Mullins C. van Bokhoven A. Lucia M. Henderson J. Sen B. Krol J. Ehrlich G. A culture-independent analysis of the microbiota of female interstitial cystitis/bladder pain syndrome participants in the MAPP research network. J. Clin. Med. 2019 8 3 415 10.3390/jcm8030415 30917614
    [Google Scholar]
  101. Zheng Z. Hu J. Li W. Ma K. Zhang C. Li K. Yao Y. Integrated microbiome and metabolome analysis reveals novel urinary microenvironmental signatures in interstitial cystitis/bladder pain syndrome patients. J. Transl. Med. 2023 21 1 266 10.1186/s12967‑023‑04115‑5 37076836
    [Google Scholar]
  102. Ceprnja M. Oros D. Melvan E. Svetlicic E. Skrlin J. Barisic K. Starcevic L. Zucko J. Starcevic A. Modeling of urinary microbiota associated with cystitis. Front. Cell. Infect. Microbiol. 2021 11 643638 10.3389/fcimb.2021.643638 33796485
    [Google Scholar]
  103. Nickel J.C. Stephens A. Landis J.R. Mullins C. van Bokhoven A. Anger J.T. Ackerman A.L. Kim J. Sutcliffe S. Krol J.E. Sen B. Hammond J. Ehrlich G.D. Urinary fungi associated with urinary symptom severity among women with interstitial cystitis/bladder pain syndrome (IC/BPS). World J. Urol. 2020 38 2 433 446 10.1007/s00345‑019‑02764‑0 31028455
    [Google Scholar]
  104. Larsen A.W. Chen Y. Crandall K.A. Icenhour C.R. Valencia C.A. Characterization of the Interstitial cystitis/Bladder pain syndrome microbiome in clinically diagnosed patients. Clin. Immunol. Rev. 2022 6 2 1 9 10.33425/2639‑8494.1047
    [Google Scholar]
  105. Robles M.T.S. Cantalupo P.G. Duray A.M. Freeland M. Murkowski M. van Bokhoven A. Stephens-Shields A.J. Pipas J.M. Imperiale M.J. Analysis of viruses present in urine from patients with interstitial cystitis. Virus Genes 2020 56 4 430 438 10.1007/s11262‑020‑01767‑z 32447589
    [Google Scholar]
  106. Jhang J.F. Liu C.D. Hsu Y.H. Chen C.C. Chen H.C. Jiang Y.H. Wu W.C. Peng C.W. Kuo H.C. EBV infection mediated BDNF expression is associated with bladder inflammation in interstitial cystitis/bladder pain syndrome with Hunner’s lesion. J. Pathol. 2023 259 3 276 290 10.1002/path.6040 36441149
    [Google Scholar]
  107. Peyronnet B. Mironska E. Chapple C. Cardozo L. Oelke M. Dmochowski R. Amarenco G. Gamé X. Kirby R. Van Der Aa F. Cornu J.N. A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment. Eur. Urol. 2019 75 6 988 1000 10.1016/j.eururo.2019.02.038 30922690
    [Google Scholar]
  108. Leron E. Weintraub A.Y. Mastrolia S.A. Schwarzman P. Overactive bladder syndrome: Evaluation and management. Curr. Urol. 2018 11 3 117 125 10.1159/000447205 29692690
    [Google Scholar]
  109. Siddiqui H. Lagesen K. Nederbragt A.J. Eri L.M. Jeansson S.L. Jakobsen K.S. Pathogens in urine from a female patient with overactive bladder syndrome detected by culture-independent high throughput sequencing: A case report. Open Microbiol. J. 2014 8 1 148 153 10.2174/1874285801408010148 25685246
    [Google Scholar]
  110. Curtiss N. Balachandran A. Krska L. Peppiatt-Wildman C. Wildman S. Duckett J. A case controlled study examining the bladder microbiome in women with Overactive Bladder (OAB) and healthy controls. Eur. J. Obstet. Gynecol. Reprod. Biol. 2017 214 31 35 10.1016/j.ejogrb.2017.04.040 28463826
    [Google Scholar]
  111. Li K. Chen C. Zeng J. Wen Y. Chen W. Zhao J. Wu P. Interplay between bladder microbiota and overactive bladder symptom severity: A cross‐sectional study. BMC Urol. 2022 22 1 39 10.1186/s12894‑022‑00990‑0 35305613
    [Google Scholar]
  112. Sze C. Pressler M. Lee J.R. Chughtai B. The gut, vaginal, and urine microbiome in overactive bladder: a systematic review. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2022 33 5 1157 1164 10.1007/s00192‑022‑05127‑3 35237854
    [Google Scholar]
  113. Jacobsen G.E. Amin K. Our knowledge of the relationship of the urinary microbiome and overactive bladder: Past, present, future. Curr. Bladder Dysfunct. Rep. 2023 18 4 285 292 10.1007/s11884‑023‑00726‑2
    [Google Scholar]
  114. Milsom I. Coyne K.S. Nicholson S. Kvasz M. Chen C.I. Wein A.J. Global prevalence and economic burden of urgency urinary incontinence: a systematic review. Eur. Urol. 2014 65 1 79 95 10.1016/j.eururo.2013.08.031 24007713
    [Google Scholar]
  115. Govender Y. Gabriel I. Minassian V. Fichorova R. The current evidence on the association between the urinary microbiome and urinary incontinence in women. Front. Cell. Infect. Microbiol. 2019 9 133 10.3389/fcimb.2019.00133 31119104
    [Google Scholar]
  116. Aoki Y. Brown H.W. Brubaker L. Cornu J.N. Daly J.O. Cartwright R. Urinary incontinence in women. Nat. Rev. Dis. Primers 2017 3 1 17043 10.1038/nrdp.2017.43
    [Google Scholar]
  117. Pearce M.M. Hilt E.E. Rosenfeld A.B. Zilliox M.J. Thomas-White K. Fok C. Kliethermes S. Schreckenberger P.C. Brubaker L. Gai X. The female urinary microbiome: A comparison of women with and without urgency urinary incontinence. MBio 2014 5 4 10 128 10.1128/mbio.01283‑14
    [Google Scholar]
  118. Khan S.R. Pearle M.S. Robertson W.G. Gambaro G. Canales B.K. Doizi S. Traxer O. Tiselius H.G. Kidney stones. Nat. Rev. Dis. Primers 2016 2 1 16008 10.1038/nrdp.2016.8 27188687
    [Google Scholar]
  119. Çiftçioglu N. Björklund M. Kuorikoski K. Bergström K. Kajander E.O. Nanobacteria: An infectious cause for kidney stone formation. Kidney Int. 1999 56 5 1893 1898 10.1046/j.1523‑1755.1999.00755.x 10571799
    [Google Scholar]
  120. Wang Z. Zhang Y. Zhang J. Deng Q. Liang H. Recent advances on the mechanisms of kidney stone formation (Review). Int. J. Mol. Med. 2021 48 2 149 10.3892/ijmm.2021.4982 34132361
    [Google Scholar]
  121. Suryavanshi M.V. Bhute S.S. Jadhav S.D. Bhatia M.S. Gune R.P. Shouche Y.S. Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures. Sci. Rep. 2016 6 1 34712 10.1038/srep34712 27708409
    [Google Scholar]
  122. Bichler K.H. Eipper E. Naber K. Braun V. Zimmermann R. Lahme S. Urinary infection stones. Int. J. Antimicrob. Agents 2002 19 6 488 498 10.1016/S0924‑8579(02)00088‑2 12135839
    [Google Scholar]
  123. Xie J. Huang J. Huang X. Peng J. Yu Z. Yuan Y. Xiao K. Guo J. Profiling the urinary microbiome in men with calcium-based kidney stones. BMC Microbiol. 2020 20 1 41 10.1186/s12866‑020‑01734‑6 32111156
    [Google Scholar]
  124. Abratt V.R. Reid S.J. Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease. Adv. Appl. Microbiol. 2010 72 63 87 10.1016/S0065‑2164(10)72003‑7 20602988
    [Google Scholar]
  125. Cui H. Distribution and drug resistance of pathogens causing urinary tract infection in patients with urinary calculi. Am. J. Transl. Res. 2021 13 9 10554 10561 34650726
    [Google Scholar]
  126. Kishorebabu A. Sree S.N. Chandralekha S.P. A review on benign prostatic hyperplasia. World J. Curr. Med. Pharm. Res. 2019 1 5 192 197
    [Google Scholar]
  127. Kim M.S. Jung S.I. The urinary tract microbiome in male genitourinary diseases: focusing on benign prostate hyperplasia and lower urinary tract symptoms. Int. Neurourol. J. 2021 25 1 3 11 10.5213/inj.2040174.087 33504133
    [Google Scholar]
  128. Takezawa K. Fujita K. Matsushita M. Motooka D. Hatano K. Banno E. Shimizu N. Takao T. Takada S. Okada K. Fukuhara S. Kiuchi H. Uemura H. Nakamura S. Kojima Y. Nonomura N. The Firmicutes/Bacteroidetes ratio of the human gut microbiota is associated with prostate enlargement. Prostate 2021 81 16 1287 1293 10.1002/pros.24223 34516694
    [Google Scholar]
  129. Li J. Li Y. Zhou L. Li C. Liu J. Liu D. Fu Y. Wang Y. Tang J. Zhou L. Tan S. Wang L. The human microbiome and benign prostatic hyperplasia: Current understandings and clinical implications. Microbiol. Res. 2024 281 127596 10.1016/j.micres.2023.127596 38215640
    [Google Scholar]
  130. Radej S. Szewc M. Maciejewski R. Prostate infiltration by Treg and Th17 cells as an immune response to Propionibacterium acnes infection in the course of benign prostatic hyperplasia and prostate cancer. Int. J. Mol. Sci. 2022 23 16 8849 10.3390/ijms23168849 36012113
    [Google Scholar]
  131. Okada K. Takezawa K. Tsujimura G. Imanaka T. Kuribayashi S. Ueda N. Hatano K. Fukuhara S. Kiuchi H. Fujita K. Motooka D. Nakamura S. Koyama Y. Shimada S. Nonomura N. Localization and potential role of prostate microbiota. Front. Cell. Infect. Microbiol. 2022 12 1048319 10.3389/fcimb.2022.1048319 36569206
    [Google Scholar]
  132. Sarkar P. Malik S. Banerjee A. Datta C. Pal D.K. Ghosh A. Saha A. Differential microbial signature associated with benign prostatic hyperplasia and prostate cancer. Front. Cell. Infect. Microbiol. 2022 12 894777 10.3389/fcimb.2022.894777 35865814
    [Google Scholar]
  133. Jain S. Samal A.G. Das B. Pradhan B. Sahu N. Mohapatra D. Behera P.K. Satpathi P.S. Mohanty A.K. Satpathi S. Senapati S. Escherichia coli, a common constituent of benign prostate hyperplasia‐associated microbiota induces inflammation and DNA damage in prostate epithelial cells. Prostate 2020 80 15 1341 1352 10.1002/pros.24063 32835423
    [Google Scholar]
  134. Bajic P. Van Kuiken M.E. Burge B.K. Kirshenbaum E.J. Joyce C.J. Wolfe A.J. Branch J.D. Bresler L. Farooq A.V. Male bladder microbiome relates to lower urinary tract symptoms. Eur. Urol. Focus 2020 6 2 376 382 10.1016/j.euf.2018.08.001 30143471
    [Google Scholar]
  135. Spinu D. Bratu O. Marcu D. Mischianu D. Huica R. Surcel M. Munteanu A. Socea B. Bodean O. Ursaciuc C. The use of ELISA and PCR in identifying correlations between viral infections and benign prostatic hypertrophy. Revista de Chimie 2018 69 3 645 649 10.37358/RC.18.3.6167
    [Google Scholar]
  136. Satoskar A.A. Parikh S.V. Nadasdy T. Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis. Nat. Rev. Nephrol. 2020 16 1 32 50 10.1038/s41581‑019‑0178‑8 31399725
    [Google Scholar]
  137. Mosquera J. Pedreañez A. Acute post-streptococcal glomerulonephritis: Analysis of the pathogenesis. Int. Rev. Immunol. 2021 40 6 381 400 10.1080/08830185.2020.1830083 33030969
    [Google Scholar]
  138. Bateman E. Mansour S. Okafor E. Arrington K. Hong B.Y. Cervantes J. Examining the efficacy of antimicrobial therapy in preventing the development of postinfectious glomerulonephritis: A systematic review and meta-analysis. Infect. Dis. Rep. 2022 14 2 176 183 10.3390/idr14020022 35314652
    [Google Scholar]
  139. Koyama A. Kobayashi M. Yamaguchi N. Yamagata K. Takano K. Nakajima M. Irie F. Goto M. Igarashi M. Iitsuka T. Aoki Y. Sakurai H. Sakurayama N. Fukao K. Glomerulonephritis associated with MRSA infection: A possible role of bacterial superantigen. Kidney Int. 1995 47 1 207 216 10.1038/ki.1995.25 7731148
    [Google Scholar]
  140. Casuscelli C. Longhitano E. Maressa V. Di Carlo S. Peritore L. Di Lorenzo S. Calabrese V. Cernaro V. Santoro D. Autoimmunity and infection in glomerular disease. Microorganisms 2023 11 9 2227 10.3390/microorganisms11092227 37764071
    [Google Scholar]
  141. Tzvi-Behr S. Frishberg Y. Megged O. Weinbrand-Goichberg J. Becher-Cohen R. Terespolsky H. Rinat C. Choshen S. Ben-Shalom E. Acute glomerulonephritis with concurrent suspected bacterial pneumonia - Is it the tip of the iceberg? Pediatr. Nephrol. 2023 1 5 10.1007/s00467‑023‑06217‑0 37943374
    [Google Scholar]
  142. Skrzypczyk P. Ofiara A. Zacharzewska A. Pańczyk-Tomaszewska M. Acute post-streptococcal glomerulonephritis – Immune-mediated acute kidney injury – Case report and literature review. Cent. Eur. J. Immunol. 2021 46 4 516 523 10.5114/ceji.2021.112244 35125952
    [Google Scholar]
  143. Yacouba A. Alou M.T. Lagier J.C. Dubourg G. Raoult D. Urinary microbiota and bladder cancer: A systematic review and a focus on uropathogens. Semin. Cancer Biol. 2022 86 Part 3 875 884 10.1016/j.semcancer.2021.12.010
    [Google Scholar]
  144. Karam A. Mjaess G. Albisinni S. El Daccache Y. Farah M. Daou S. Kazzi H. Hassoun R. Bou Kheir G. Aoun F. Roumeguère T. Uncovering the role of urinary microbiota in urological tumors: a systematic review of literature. World J. Urol. 2022 40 4 951 964 10.1007/s00345‑021‑03924‑x 34997296
    [Google Scholar]
  145. Alajeeli F. Al-Karawi A.S. Abid F.M. A-lKurwi, M.; Abdulla, M. Revealing the urinary microbiota in prostate cancer: A comprehensive review unveiling insights into pathogenesis and clinical application. Al-Salam. J. Med. Sci. 2024 3 1 45 54 10.55145/ajbms.2024.03.01.008
    [Google Scholar]
  146. Tsai K.Y. Wu D.C. Wu W.J. Wang J.W. Juan Y.S. Li C.C. Liu C.J. Lee H.Y. Exploring the association between gut and urine microbiota and prostatic disease including benign prostatic hyperplasia and prostate cancer using 16S rRNA sequencing. Biomedicines 2022 10 11 2676 10.3390/biomedicines10112676 36359196
    [Google Scholar]
  147. Gupta S. Kanwar S.S. The influence of dysbiosis on kidney stones that risk up renal cell carcinoma (RCC). Semin. Cancer Biol. 2021 70 134 138 10.1016/j.semcancer.2020.06.011
    [Google Scholar]
  148. Wu P. Zhang G. Zhao J. Chen J. Chen Y. Huang W. Zhong J. Zeng J. Profiling the urinary microbiota in male patients with bladder cancer in China. Front. Cell. Infect. Microbiol. 2018 8 167 10.3389/fcimb.2018.00167 29904624
    [Google Scholar]
  149. Saeed A. Riaz S. Riaz S. Study of urinary tract infection in patients suffering from cancer. J. Cancer Res. Rev. Rep 2020 2 2 1 15 10.47363/JCRR/2020(2)124
    [Google Scholar]
  150. Heidler S. Lusuardi L. Madersbacher S. Freibauer C. The microbiome in benign renal tissue and in renal cell carcinoma. Urol. Int. 2020 104 3-4 247 252 10.1159/000504029 31715602
    [Google Scholar]
  151. Randazzo G. Bovolenta E. Ceccato T. Reitano G. Betto G. Novara G. Iafrate M. Morlacco A. Dal Moro F. Zattoni F. Urinary microbiome and urological cancers: A mini review. Front. Urol. 2024 4 1367720 10.3389/fruro.2024.1367720
    [Google Scholar]
  152. Shrestha E. White J.R. Yu S.H. Kulac I. Ertunc O. De Marzo A.M. Yegnasubramanian S. Mangold L.A. Partin A.W. Sfanos K.S. Profiling the urinary microbiome in men with positive versus negative biopsies for prostate cancer. J. Urol. 2018 199 1 161 171 10.1016/j.juro.2017.08.001 28797714
    [Google Scholar]
  153. Alanee S. El-Zawahry A. Dynda D. Dabaja A. McVary K. Karr M. Braundmeier-Fleming A. A prospective study to examine the association of the urinary and fecal microbiota with prostate cancer diagnosis after transrectal biopsy of the prostate using 16sRNA gene analysis. Prostate 2019 79 1 81 87 10.1002/pros.23713 30117171
    [Google Scholar]
  154. Yu H. Meng H. Zhou F. Ni X. Shen S. Das U.N. Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia. Arch. Med. Sci. 2015 2 2 385 394 10.5114/aoms.2015.50970 25995756
    [Google Scholar]
  155. de Deus A. Gonçalves G. da Silva J. de Jesus L.C. Azevedo-Santos A.P.S. Dall Agnol H. Pereira S.R. Microbiome reveals inflammatory‐related bacteria and putative functional pathways involved in human papillomavirus‐associated penile squamous cell carcinoma. Andrology 2024 12 4 809 820 10.1111/andr.13545 37840240
    [Google Scholar]
  156. Bi H. Tian Y. Song C. Li J. Liu T. Chen Z. Chen C. Huang Y. Zhang Y. Urinary microbiota – A potential biomarker and therapeutic target for bladder cancer. J. Med. Microbiol. 2019 68 10 1471 1478 10.1099/jmm.0.001058 31418671
    [Google Scholar]
  157. Bajic P. Wolfe A.J. Gupta G.N. The urinary microbiome: Implications in bladder cancer pathogenesis and therapeutics. Urology 2019 126 10 15 10.1016/j.urology.2018.12.034 30615894
    [Google Scholar]
  158. Friedrich V. Choi H.W. The urinary microbiome: role in bladder cancer and treatment. Diagnostics (Basel) 2022 12 9 2068 10.3390/diagnostics12092068 36140470
    [Google Scholar]
  159. Hrbáček J. Hanáček V. Kadlečková D. Cirbusová A. Čermák P. Tachezy R. Zachoval R. Saláková M. Urinary shedding of common DNA viruses and their possible association with bladder cancer: A qPCR-based study. Neoplasma 2023 70 2 311 318 10.4149/neo_2023_220703N681 37226931
    [Google Scholar]
  160. Yang H. Luo Z.Y. Lin F. Li L.J. Lu M. Xie L.X. Yang L.Y. Comparison of urine and genital samples for detecting human papillomavirus (HPV) in clinical patients. Obstet. Gynecol. Int. 2023 2023 1 1 8 10.1155/2023/7483783 37020494
    [Google Scholar]
  161. Reggiani F. L’Imperio V. Calatroni M. Pagni F. Sinico R.A. Goodpasture syndrome and anti-glomerular basement membrane disease. Clin. Exp. Rheumatol. 2023 41 4 964 974 10.55563/clinexprheumatol/tep3k5 36995324
    [Google Scholar]
  162. Gesualdo L. Di Leo V. Coppo R. The mucosal immune system and IgA nephropathy. Semin. Immunopathol. 2021 43 5 657 668 10.1007/s00281‑021‑00871‑y 34642783
    [Google Scholar]
  163. Suzuki S. Nakatomi Y. Odani S. Sato H. Gejyo F. Arakawa M. Circulating IgA, IgG, and IgM class antibody against Haemophilus parainfluenzae antigens in patients with IgA nephropathy. Clin. Exp. Immunol. 2003 104 2 306 311 10.1046/j.1365‑2249.1996.09703.x 8625525
    [Google Scholar]
  164. Sugino H. Sawada Y. Nakamura M. IgA vasculitis: etiology, treatment, biomarkers and epigenetic changes. Int. J. Mol. Sci. 2021 22 14 7538 10.3390/ijms22147538 34299162
    [Google Scholar]
  165. Keri K.C. Blumenthal S. Kulkarni V. Beck L. Chongkrairatanakul T. Primary membranous nephropathy: comprehensive review and historical perspective. Postgrad. Med. J. 2019 95 1119 23 31 10.1136/postgradmedj‑2018‑135729 30683678
    [Google Scholar]
  166. Almaani S. Meara A. Rovin B.H. Update on Lupus Nephritis. Clin. J. Am. Soc. Nephrol. 2017 12 5 825 835 10.2215/CJN.05780616 27821390
    [Google Scholar]
  167. Dhillon S. Higgins R.M. Interstitial nephritis. Postgrad. Med. J. 1997 73 857 151 155 10.1136/pgmj.73.857.151 9135830
    [Google Scholar]
  168. Marcu I. Campian E. Tu F. Interstitial cystitis/bladder pain syndrome. Semin. Reprod. Med. 2018 36 2 123 135 10.1055/s‑0038‑1676089 30566978
    [Google Scholar]
  169. Karlsen T.H. Folseraas T. Thorburn D. Vesterhus M. Primary sclerosing cholangitis – A comprehensive review. J. Hepatol. 2017 67 6 1298 1323 10.1016/j.jhep.2017.07.022 28802875
    [Google Scholar]
  170. Hanson L.A. Ahlstedt S. Fasth A. Hagberg M. Kaijser B. Mattsby-Baltzer I. Svanborg-Eden C. Immunological aspects of pyelonephritis. Contrib. Nephrol. 1979 16 16 21 10.1159/000402868
    [Google Scholar]
  171. Rifai A.O. Denig K.M. Caza T. Webb S.M. Rifai S. Khan S. Dahan S. Alamin S. Antitubular basement membrane antibody disease associated with nivolumab infusion and concomitant acute pyelonephritis leading to acute kidney injury: A case report and literature review. Case Rep. Nephrol. 2023 2023 1 5 10.1155/2023/6681756 37051373
    [Google Scholar]
  172. Lu J.C. Shen J.M. Hu X.C. Peng L.P. Hong Z.W. Yao B. Identification and preliminary study of immunogens involved in autoimmune prostatitis in human males. Prostate 2018 78 14 1092 1102 10.1002/pros.23684 29947032
    [Google Scholar]
  173. Hyun M. Lee J.Y. Lim K.R. Kim H. Clinical characteristics of uncomplicated acute pyelonephritis caused by Escherichia coli and Klebsiella pneumoniae. Infect. Dis. Ther. 2024 13 3 581 595 10.1007/s40121‑024‑00940‑3 38460083
    [Google Scholar]
  174. Jirillo E. Palmirotta R. Colella M. Santacroce L. A bird’s-eye view of the pathophysiologic role of the human urobiota in health and disease: Can we modulate it? Pathophysiology 2024 31 1 52 67 10.3390/pathophysiology31010005 38390942
    [Google Scholar]
  175. Kline K. Lewis A. Gram-positive uropathogens, polymicrobial urinary tract infection, and the emerging microbiota of the urinary tract. Urinary Tract Infections: Molecular Pathogenesis and Clinical Management, Second Edition Wiley 2017 459 502 10.1128/microbiolspec.UTI‑0012‑2012
    [Google Scholar]
  176. Alteri C.J. Himpsl S.D. Mobley H.L.T. Preferential use of central metabolism in vivo reveals a nutritional basis for polymicrobial infection. PLoS Pathog. 2015 11 1 e1004601 10.1371/journal.ppat.1004601 25568946
    [Google Scholar]
  177. Keogh D. Tay W.H. Ho Y.Y. Dale J.L. Chen S. Umashankar S. Williams R.B.H. Chen S.L. Dunny G.M. Kline K.A. Enterococcal metabolite cues facilitate interspecies niche modulation and polymicrobial infection. Cell Host Microbe 2016 20 4 493 503 10.1016/j.chom.2016.09.004 27736645
    [Google Scholar]
  178. Mohamed A.H. Mohamud H.A. Emphysematous pyelonephritis caused by candida species: A case report and outcome of 1 year follow-up. Urol. Case Rep. 2020 30 101113 10.1016/j.eucr.2020.101113 32055447
    [Google Scholar]
  179. Zhang J. Li Q. Lin X. Wu Z. He L. Wang W. Cao Q. Immuno-histochemistry analysis of Helicobacter pylori antigen in renal biopsy specimens from patients with glomerulonephritis. Saudi J. Kidney Dis. Transpl. 2013 24 4 751 758 10.4103/1319‑2442.113871 23816725
    [Google Scholar]
  180. Ogura Y. Suzuki S. Shirakawa T. Masuda M. Nakamura H. Iijima K. Yoshikawa N. Haemophilus parainfluenzae antigen and antibody in children with IgA nephropathy and Henoch-Schönlein nephritis. Am. J. Kidney Dis. 2000 36 1 47 52 10.1053/ajkd.2000.8264 10873871
    [Google Scholar]
  181. Masuda M. Nakanishi K. Yoshizawa N. Iijima K. Yoshikawa N. Group A streptococcal antigen in the glomeruli of children with henoch-schönlein nephritis. Am. J. Kidney Dis. 2003 41 2 366 370 10.1053/ajkd.2003.50045 12552498
    [Google Scholar]
  182. Schmitt R. Carlsson F. Mörgelin M. Tati R. Lindahl G. Karpman D. Tissue deposits of IgA-binding streptococcal M proteins in IgA nephropathy and Henoch-Schonlein purpura. Am. J. Pathol. 2010 176 2 608 618 10.2353/ajpath.2010.090428 20056836
    [Google Scholar]
  183. Kronbichler A. Kerschbaum J. Mayer G. The influence and role of microbial factors in autoimmune kidney diseases: a systematic review. J. Immunol. Res. 2015 2015 1 13 10.1155/2015/858027 26078982
    [Google Scholar]
  184. Elsayed N.S. Wolfe A.J. Burk R.D. Urine microbiome in individuals with an impaired immune system. Front. Cell. Infect. Microbiol. 2024 13 1308665 10.3389/fcimb.2023.1308665 38274734
    [Google Scholar]
  185. Liu F. Ling Z. Xiao Y. Yang Q. Zheng L. Jiang P. Li L. Wang W. Characterization of the urinary microbiota of elderly women and the effects of type 2 diabetes and urinary tract infections on the microbiota. Oncotarget 2017 8 59 100678 100690 10.18632/oncotarget.21126 29246012
    [Google Scholar]
  186. Liu F. Ling Z. Xiao Y. Yang Q. Wang B. Zheng L. Jiang P. Li L. Wang W. Alterations of urinary microbiota in type 2 diabetes mellitus with hypertension and/or hyperlipidemia. Front. Physiol. 2017 8 126 10.3389/fphys.2017.00126 28316574
    [Google Scholar]
  187. Graells T. Lin Y-T. Ahmad S. Fall T. Ärnlöv J. The urinary microbiome in association with diabetes and diabetic kidney disease: A systematic review. bioRxiv 20 1 eo317960 10.1101/2024.09.21.614275
    [Google Scholar]
  188. Spighi L. Broccatelli A. Notaristefano F. Verdecchia P. Ambrosio G. Cavallini C. Peri-myocarditis during urinary tract infection by Escherichia coli. G. Ital. Cardiol. (Rome) 2020 21 3 224 227 10.1714/3306.32771 32100735
    [Google Scholar]
  189. Oudih M. Harhara T. Escherichia coli bacteremia due to urinary tract infection complicated by acute myocarditis: A rare complication. SAGE Open Med. Case Rep 2021 9 2050313 x 211023674 10.1177/2050313X211023674 34211715
    [Google Scholar]
  190. Ivanov I.B. Kuzmin M.D. Gritsenko V.A. Microflora of the seminal fluid of healthy men and men suffering from chronic prostatitis syndrome. Int. J. Androl. 2009 32 5 462 467 10.1111/j.1365‑2605.2008.00878.x 18328042
    [Google Scholar]
  191. Nickel J.C. Stephens A. Landis J.R. Chen J. Mullins C. van Bokhoven A. Lucia M.S. Melton-Kreft R. Ehrlich G.D. Network M.R. Search for microorganisms in men with urologic chronic pelvic pain syndrome: a culture-independent analysis in the MAPP research network. J. Urol. 2015 194 1 127 135 10.1016/j.juro.2015.01.037 25596358
    [Google Scholar]
  192. Shoskes D.A. Altemus J. Polackwich A.S. Tucky B. Wang H. Eng C. The urinary microbiome differs significantly between patients with chronic prostatitis/chronic pelvic pain syndrome and controls as well as between patients with different clinical phenotypes. Urology 2016 92 26 32 10.1016/j.urology.2016.02.043 26970449
    [Google Scholar]
  193. Mändar R. Punab M. Korrovits P. Türk S. Ausmees K. Lapp E. Preem J.K. Oopkaup K. Salumets A. Truu J. Seminal microbiome in men with and without prostatitis. Int. J. Urol. 2017 24 3 211 216 10.1111/iju.13286 28147438
    [Google Scholar]
  194. Miyake M. Tatsumi Y. Ohnishi K. Fujii T. Nakai Y. Tanaka N. Fujimoto K. Prostate diseases and microbiome in the prostate, gut, and urine. Prostate Int. 2022 10 2 96 107 10.1016/j.prnil.2022.03.004 35510078
    [Google Scholar]
  195. Venturini S. Reffo I. Avolio M. Basaglia G. Del Fabro G. Callegari A. Tonizzo M. Sabena A. Rondinella S. Mancini W. Conte C. Crapis M. The management of recurrent urinary tract infection: Non-antibiotic bundle treatment. Probiotics Antimicrob. Proteins 2024 16 5 1857 1865 10.1007/s12602‑023‑10141‑y 37584833
    [Google Scholar]
  196. Fisher J.F. Sobel J.D. Kauffman C.A. Newman C.A. Candida urinary tract infections - Treatment. Clin. Infect. Dis. 2011 52 Suppl. 6 S457 S466 10.1093/cid/cir112 21498839
    [Google Scholar]
  197. Amaya-Tapia G. Ibarra-Nieto G. Rivas O.C. Sánchez J.L.G. Urinary tract infection in HIV/AIDS patients. Urinary Tract Infections - New Insights. IntechOpen 2023 10.5772/intechopen.110017
    [Google Scholar]
  198. Pessoa W.F.B. Melgaço A.C.C. Almeida M.E. Santos T.F. Romano C.C. Chapter22 - Probiotics for urinary tract disease prevention and treatment.Probiotics for Human Nutrition in Health. and Disease. Elsevier 2022 513 536 10.1016/B978‑0‑323‑89908‑6.00011‑X
    [Google Scholar]
  199. Ahmed R. kamil, M.; Kamal, L.; Ahmed, H. The mechanisms of Lactobacillus activities: Probiotic importance of Lactobacillus species. Egypt. Acad. J. Biol. Sci. E Med. Entomol. Parasitol. 2021 13 2 45 63 10.21608/eajbse.2021.210635
    [Google Scholar]
  200. Iannitti T. Palmieri B. Therapeutical use of probiotic formulations in clinical practice. Clin. Nutr. 2010 29 6 701 725 10.1016/j.clnu.2010.05.004 20576332
    [Google Scholar]
  201. Zagaglia C. Ammendolia M.G. Maurizi L. Nicoletti M. Longhi C. Urinary tract infections caused by uropathogenic Escherichia coli strains - New strategies for an old pathogen. Microorganisms 2022 10 7 1425 10.3390/microorganisms10071425 35889146
    [Google Scholar]
  202. Kamel M. Aleya S. Alsubih M. Aleya L. Microbiome dynamics: A paradigm shift in combatting infectious diseases. J. Pers. Med. 2024 14 2 217 10.3390/jpm14020217 38392650
    [Google Scholar]
  203. Schwartz L. de Dios Ruiz-Rosado J. Stonebrook E. Becknell B. Spencer J.D. Uropathogen and host responses in pyelonephritis. Nat. Rev. Nephrol. 2023 19 10 658 671 10.1038/s41581‑023‑00737‑6 37479904
    [Google Scholar]
  204. Kenneally C. Murphy C.P. Sleator R.D. Culligan E.P. The urinary microbiome and biological therapeutics: Novel therapies for urinary tract infections. Microbiol. Res. 2022 259 127010 10.1016/j.micres.2022.127010 35338973
    [Google Scholar]
  205. Abdulsalam A.A. Saleh M.K. Effect of colicin from E. coli product on some species of gram-negative bacteria isolated from Urinary Tract infections. J. Educ. Sci. Stud 2021 3 17 10.1155/2014/869610
    [Google Scholar]
  206. Roy S.M. Riley M.A. Evaluation of the potential of colicins to prevent extraluminal contamination of urinary catheters by Escherichia coli. Int. J. Antimicrob. Agents 2019 54 5 619 625 10.1016/j.ijantimicag.2019.07.004 31284040
    [Google Scholar]
  207. Bao J. Wu N. Zeng Y. Chen L. Li L. Yang L. Zhang Y. Guo M. Li L. Li J. Tan D. Cheng M. Gu J. Qin J. Liu J. Li S. Pan G. Jin X. Yao B. Guo X. Zhu T. Le S. Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae. Emerg. Microbes Infect. 2020 9 1 771 774 10.1080/22221751.2020.1747950 32212918
    [Google Scholar]
  208. Zalewska-Piątek B. Piątek R. Phage therapy as a novel strategy in the treatment of urinary tract infections caused by E. coli. Antibiotics 2020 9 6 304 10.3390/antibiotics9060304 32517088
    [Google Scholar]
  209. Petrovic Fabijan A. Iredell J. Danis-Wlodarczyk K. Kebriaei R. Abedon S.T. Translating phage therapy into the clinic: Recent accomplishments but continuing challenges. PLoS Biol. 2023 21 5 e3002119 10.1371/journal.pbio.3002119 37220114
    [Google Scholar]
  210. Stapleton A.E. Au-Yeung M. Hooton T.M. Fredricks D.N. Roberts P.L. Czaja C.A. Yarova-Yarovaya Y. Fiedler T. Cox M. Stamm W.E. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin. Infect. Dis. 2011 52 10 1212 1217 10.1093/cid/cir183 21498386
    [Google Scholar]
  211. Hosseini M. Yousefifard M. Ataei N. Oraii A. Mirzay Razaz J. Izadi A. The efficacy of probiotics in prevention of urinary tract infection in children: A systematic review and meta-analysis. J. Pediatr. Urol. 2017 13 6 581 591 10.1016/j.jpurol.2017.08.018 29102297
    [Google Scholar]
  212. New F.J. Theivendrampillai S. Juliebø-Jones P. Somani B. Role of probiotics for recurrent UTIs in the twenty-first century: A systematic review of literature. Curr. Urol. Rep. 2022 23 2 19 28 10.1007/s11934‑022‑01085‑x 35156175
    [Google Scholar]
  213. Daniel M. Szymanik-Grzelak H. Turczyn A. Pańczyk-Tomaszewska M. Lactobacillus rhamnosus PL1 and Lactobacillus plantarum PM1 versus placebo as a prophylaxis for recurrence urinary tract infections in children: A study protocol for a randomised controlled trial. BMC Urol. 2020 20 1 168 10.1186/s12894‑020‑00723‑1 33097017
    [Google Scholar]
  214. Meena J. Thomas C.C. Kumar J. Raut S. Hari P. Non-antibiotic interventions for prevention of urinary tract infections in children: a systematic review and meta-analysis of randomized controlled trials. Eur. J. Pediatr. 2021 180 12 3535 3545 10.1007/s00431‑021‑04091‑2 34156540
    [Google Scholar]
  215. Abdullatif V.A. Sur R.L. Eshaghian E. Gaura K.A. Goldman B. Panchatsharam P.K. Williams N.J. Abbott J.E. Efficacy of probiotics as prophylaxis for urinary tract infections in premenopausal women: a systematic review and meta-analysis. Cureus 2021 13 10 e18843 10.7759/cureus.18843 34671514
    [Google Scholar]
  216. Das S. Ameeruddin S. Probiotics in common urological conditions: a narrative review. Longhua Chin. Med. 2022 5 14 10.21037/lcm‑21‑62
    [Google Scholar]
  217. Fazly Bazzaz B.S. Darvishi Fork S. Ahmadi R. Khameneh B. Deep insights into urinary tract infections and effective natural remedies. Afr. J. Urol. 2021 27 1 6 10.1186/s12301‑020‑00111‑z
    [Google Scholar]
  218. Andreu A. Lactobacillus as a probiotic for preventing urogenital infections. Rev. Med. Microbiol. 2004 15 1 1 6 10.1097/01.revmedmi.0000131423.90481.82
    [Google Scholar]
  219. Pascual L. Barberis L. Prevention strategy of urogenital infections by using Lactobacilli with probiotic properties. Urinary Tract Infections. Tenke P. Rijeka, Croatia IntechOpen 2011 245 264 10.5772/24716
    [Google Scholar]
  220. Anukam K.C. Hayes K. Summers K. Reid G. Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 may help downregulate TNF-Alpha, IL-6, IL-8, IL-10 and IL-12 (p70) in the neurogenic bladder of spinal cord injured patient with urinary tract infections: a two-case study. Adv. Urol. 2009 2009 1 1 5 10.1155/2009/680363 19753131
    [Google Scholar]
  221. Asahara T. Nomoto K. Watanuki M. Yokokura T. Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection. Antimicrob. Agents Chemother. 2001 45 6 1751 1760 10.1128/AAC.45.6.1751‑1760.2001 11353622
    [Google Scholar]
  222. Storm D.W. Koff S.A. Horvath D.J. Li B. Justice S.S. In vitro analysis of the bactericidal activity of Escherichia coli Nissle 1917 against pediatric uropathogens. J. Urol. 2011 186 Suppl. 4 1678 1683 10.1016/j.juro.2011.04.021 21855931
    [Google Scholar]
  223. Ayivi R.D. Gyawali R. Krastanov A. Aljaloud S.O. Worku M. Tahergorabi R. Silva R.C. Ibrahim S.A. Lactic acid bacteria: Food safety and human health applications. Dairy 2020 1 3 202 232 10.3390/dairy1030015
    [Google Scholar]
  224. Voidarou C. Alexopoulos A. Tsinas A. Rozos G. Tzora A. Skoufos I. Varzakas T. Bezirtzoglou E. Effectiveness of bacteriocin-producing lactic acid bacteria and bifidobacterium isolated from honeycombs against spoilage microorganisms and pathogens isolated from fruits and vegetables. Appl. Sci. 2020 10 20 7309 10.3390/app10207309
    [Google Scholar]
  225. Song C.H. Kim Y.H. Naskar M. Hayes B.W. Abraham M.A. Noh J.H. Suk G. Kim M.J. Cho K.S. Shin M. Lee E.J. Abraham S.N. Choi H.W. Lactobacillus crispatus limits bladder uropathogenic E. coli infection by triggering a host type I interferon response. Proc. Natl. Acad. Sci. USA 2022 119 33 e2117904119 10.1073/pnas.2117904119 35939684
    [Google Scholar]
  226. Hari P. Meena J. Vesicoureteral reflux and recurrent urinary tract infections. Asian J. Pediatr. Nephrol 2019 2 2 61 70 10.4103/AJPN.AJPN_26_19
    [Google Scholar]
  227. González de Llano D. Moreno-Arribas M.V. Bartolomé B. Cranberry polyphenols and prevention against urinary tract infections: Relevant considerations. Molecules 2020 25 15 3523 10.3390/molecules25153523 32752183
    [Google Scholar]
  228. Amábile-Cuevas C.F. Ascorbate and antibiotics, at concentrations attainable in urine, can inhibit the growth of resistant strains of Escherichia coli cultured in synthetic human urine. Antibiotics 2023 12 6 985 10.3390/antibiotics12060985 37370304
    [Google Scholar]
  229. Pani A. Valeria L. Dugnani S. Senatore M. Scaglione F. Pharmacodynamics of D-mannose in the prevention of recurrent urinary infections. J. Chemother. 2022 34 7 459 464 10.1080/1120009X.2022.2061184 35416116
    [Google Scholar]
  230. Ala-Jaakkola R. Laitila A. Ouwehand A.C. Lehtoranta L. Role of D-mannose in urinary tract infections – A narrative review. Nutr. J. 2022 21 1 18 10.1186/s12937‑022‑00769‑x 35313893
    [Google Scholar]
  231. O’Doherty K.C. Virani A. Wilcox E.S. The human microbiome and public health: social and ethical considerations. Am. J. Public Health 2016 106 3 414 420 10.2105/AJPH.2015.302989 26794165
    [Google Scholar]
  232. Ma Y. Chen H. Lan C. Ren J. Help, hope and hype: ethical considerations of human microbiome research and applications. Protein Cell 2018 9 5 404 415 10.1007/s13238‑018‑0537‑4 29675808
    [Google Scholar]
  233. Ahmed E. Hens K. Microbiome in precision psychiatry: An overview of the ethical challenges regarding microbiome big data and microbiome-based interventions. AJOB Neurosci. 2022 13 4 270 286 10.1080/21507740.2021.1958096 34379050
    [Google Scholar]
  234. Hooton T.M. Bradley S.F. Cardenas D.D. Colgan R. Geerlings S.E. Rice J.C. Saint S. Schaeffer A.J. Tambayh P.A. Tenke P. Nicolle L.E. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin. Infect. Dis. 2010 50 5 625 663 10.1086/650482 20175247
    [Google Scholar]
  235. Shamarina D. Stoyantcheva I. Mason C.E. Bibby K. Elhaik E. Communicating the promise, risks, and ethics of large-scale, open space microbiome and metagenome research. Microbiome 2017 5 1 132 10.1186/s40168‑017‑0349‑4 28978331
    [Google Scholar]
  236. Ogunjobi T.T. Okafor A.M-A. Ohuonu N.I. Nebolisa N.M. Abimbolu A.K. Ajayi R.O. Afuape A.R. Ojajuni M.G. Ogunbor O.O. Elijah E.U. Navigating the complexity of the human microbiome: Implications for biomedical science and disease treatment. Medinformatics 2024 10.47852/bonviewMEDIN42022988
    [Google Scholar]
  237. Zhang J. Lei Y. Du H. Li Z. Wang X. Yang D. Gao F. Li J. Exploring urinary microbiome: Insights into neurogenic bladder and improving management of urinary tract infections. Front. Cell. Infect. Microbiol. 2025 15 1512891 10.3389/fcimb.2025.1512891 40235931
    [Google Scholar]
/content/journals/mrmc/10.2174/0113895575398906250825113635
Loading
An Overview of the Association of the Urinary Tract Microbiome with Various Diseases and Implications for Therapeutics
Bentham Science Publishers ; https://doi.org/10.2174/0113895575398906250825113635
/content/journals/mrmc/10.2174/0113895575398906250825113635
/content/journals/mrmc/10.2174/0113895575398906250825113635
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: culturing ; dysbiosis ; probiotics ; metagenomic sequencing ; microbiome ; urinary tract diseases ; Urinary tract

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test